diphenhydramine has been researched along with Colorectal Neoplasms in 4 studies
Diphenhydramine: A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects.
diphenhydramine : An ether that is the benzhydryl ether of 2-(dimethylamino)ethanol. It is a H1-receptor antagonist used as a antipruritic and antitussive drug.
antitussive : An agent that suppresses cough. Antitussives have a central or a peripheral action on the cough reflex, or a combination of both. Compare with expectorants, which are considered to increase the volume of secretions in the respiratory tract, so facilitating their removal by ciliary action and coughing, and mucolytics, which decrease the viscosity of mucus, facilitating its removal by ciliary action and expectoration.
Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Temsirolimus (CCI-779) is a novel inhibitor of the mammalian target of rapamycin." | 2.75 | A Phase 1 clinical study of temsirolimus (CCI-779) in Japanese patients with advanced solid tumors. ( Fujisaka, Y; Horiike, A; Tamura, T; Yamada, Y; Yamamoto, N, 2010) |
| " Except for benzodiazepines, which were dosed higher in women than men, equal doses of sedation were given to female and male patients." | 1.42 | Practice patterns of sedation for colonoscopy. ( Childers, RE; Sonnenberg, A; Williams, JL, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bitar, H | 1 |
| Zia, H | 1 |
| Bashir, M | 1 |
| Parava, P | 1 |
| Hanafi, M | 1 |
| Tierney, W | 1 |
| Madhoun, M | 1 |
| Childers, RE | 1 |
| Williams, JL | 1 |
| Sonnenberg, A | 1 |
| Fujisaka, Y | 1 |
| Yamada, Y | 1 |
| Yamamoto, N | 1 |
| Horiike, A | 1 |
| Tamura, T | 1 |
| Siu, SW | 1 |
| Chan, WL | 1 |
| Liu, KY | 1 |
| Choy, TS | 1 |
| Leung, TW | 1 |
| Au, KH | 1 |
1 trial available for diphenhydramine and Colorectal Neoplasms
| Article | Year |
|---|---|
A Phase 1 clinical study of temsirolimus (CCI-779) in Japanese patients with advanced solid tumors.
Topics: Adult; Aged; Anti-Allergic Agents; Antineoplastic Agents; Area Under Curve; Carcinoma, Renal Cell; C | 2010 |
3 other studies available for diphenhydramine and Colorectal Neoplasms
| Article | Year |
|---|---|
Impact of fellowship training level on colonoscopy quality and efficiency metrics.
Topics: Adenoma; Adjuvants, Anesthesia; Aged; Clinical Competence; Colonic Polyps; Colonoscopy; Colorectal N | 2018 |
Practice patterns of sedation for colonoscopy.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Biopsy; Black or African American; Cath | 2015 |
Re-challenging patients with oxaliplatin allergy: the successful use of a standardised pre-medication protocol in a single institute.
Topics: Adult; Aged; Anaphylaxis; Anesthetics, Local; Anti-Inflammatory Agents; Antineoplastic Agents; Color | 2011 |